drugset / Trial / NCT01815086
Radioimmunoimaging of Light Chain (AL) Amyloidosis
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to determine the capability of a radiolabeled amyloid-reactive monoclonal antibody (mAb) to document the presence and distribution of amyloid deposits by PET/CT imaging in patients with AL amyloidosis.
Timeline
- Start
- 2008-12
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anselamimab | Protein / enzyme biologic | 1 mg | Intravenous |
| Subject | Anselamimab | Protein / enzyme biologic | 74 mbq | Intravenous |